Global burden of atrial fibrillation/flutter: Trends from 1990 to 2019 and projections until 2044

被引:5
作者
Ma, Qunchao [1 ]
Zhu, Jinyun [1 ]
Zheng, Pingping [3 ]
Zhang, Jiaru [4 ]
Xia, Xiangyang [1 ]
Zhao, Yun [5 ]
Cheng, Qingqiang [2 ]
Zhang, Ning [2 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Dept Cardiol, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
[2] Westlake Univ, Affiliated Hangzhou Peoples Hosp 1, Coll Med, Dept Cardiol, Hangzhou 310006, Zhejiang, Peoples R China
[3] Westlake Univ, Affiliated Hangzhou Peoples Hosp 1, Coll Med, Dept Emergency, Hangzhou 310006, Zhejiang, Peoples R China
[4] Fujian Med Univ, Affiliated Hosp 1, Dept Cardiol, Fuzhou 350000, Fujian, Peoples R China
[5] Shandong First Med Univ, Affiliated Hosp 2, Dept Ultrasound, Tai An 271000, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Atrial fibrillation/atrial flutter; Disease burden; Estimated annual percentage change; Age-standardized rate; Risk factors; Prediction; RISK-FACTOR; BLOOD-PRESSURE; STROKE RISK; PREVALENCE; MORTALITY; DISEASE; RHYTHM; ANTICOAGULATION; STRATIFICATION; EPIDEMIOLOGY;
D O I
10.1016/j.heliyon.2024.e24052
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aims: Atrial fibrillation/atrial flutter (AF/AFL) is a critical public health issue worldwide, and its epidemiological patterns have changed over the decades. This work aimed to assess the global trends of AF/AFL and attributable risks from 1990 to 2019. Methods and results: The present study utilized data from the Global Burden of Disease Study 2019 to examine the temporal trends, attributable risks, and projections of AF/AFL. The estimated annual percentage change (EAPC) and age -standardized rate (ASR) were employed for this purpose. The findings revealed that in 2019, AF/AFL accounted for 4.72 million incident cases, 59.70 million prevalent cases, 0.32 million deaths, and 8.39 million disability -adjusted life years (DALYs). Furthermore, the results indicated that males under 70 years of age had a higher incidence, prevalence, and DALYs than females, while the rates were similar for both genders between 70 and 74 years. However, this pattern was reversed in individuals over the age of 75, with females exhibiting a higher total incidence, prevalence, and DALYs than males. The agestandardized rates (ASRs) of prevalence, incidence, mortality, and DALYs increased with an increase in the socio-demographic index (SDI). The three primary contributors to AF/AFL were high systolic blood pressure, high body -mass index, and smoking. Majority of risk factors exhibited a unimodal distribution, with a peak between the ages of 50 and 70. Conclusions: The disease burden of AF/AFL is still severe worldwide and getting worse. To encourage prevention and treatment, systematic regional surveillance of AF/AFL should be put in place.
引用
收藏
页数:16
相关论文
共 44 条
[1]   Atrial Fibrillation and Heart Failure Treatment Considerations for a Dual Epidemic [J].
Anter, Elad ;
Jessup, Mariell ;
Callans, David J. .
CIRCULATION, 2009, 119 (18) :2516-2525
[2]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[3]   Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration [J].
Brandes, Axel ;
Stavrakis, Stavros ;
Freedman, Ben ;
Antoniou, Sotiris ;
Boriani, Giuseppe ;
Camm, A. John ;
Chow, Clara K. ;
Ding, Eric ;
Engdahl, Johan ;
Gibson, Michael M. ;
Golovchiner, Gregory ;
Glotzer, Taya ;
Guo, Yutao ;
Healey, Jeff S. ;
Hills, Mellanie T. ;
Johnson, Linda ;
Lip, Gregory Y. H. ;
Lobban, Trudie ;
Macfarlane, Peter W. ;
Marcus, Gregory M. ;
McManus, David D. ;
Neubeck, Lis ;
Orchard, Jessica ;
Perez, Marco V. ;
Schnabel, Renate B. ;
Smyth, Breda ;
Steinhubl, Steven ;
Turakhia, Mintu P. .
CIRCULATION, 2022, 146 (19) :1461-1474
[4]   Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation - The Strategies of Treatment of Atrial Fibrillation (STAF) study [J].
Carlsson, J ;
Miketic, S ;
Windeler, J ;
Cuneo, A ;
Haun, S ;
Micus, S ;
Walter, S ;
Tebbe, U .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) :1690-1696
[5]   Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study [J].
Chugh, Sumeet S. ;
Havmoeller, Rasmus ;
Narayanan, Kumar ;
Singh, David ;
Rienstra, Michiel ;
Benjamin, Emelia J. ;
Gillum, Richard F. ;
Kim, Young-Hoon ;
McAnulty, John H. ;
Zheng, Zhi-Jie ;
Forouzanfar, Mohammad H. ;
Naghavi, Mohsen ;
Mensah, George A. ;
Ezzati, Majid ;
Murray, Christopher J. L. .
CIRCULATION, 2014, 129 (08) :837-847
[6]   Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association [J].
Chung, Mina K. ;
Eckhardt, Lee L. ;
Chen, Lin Y. ;
Ahmed, Haitham M. ;
Gopinathannair, Rakesh ;
Joglar, Jose A. ;
Noseworthy, Peter A. ;
Pack, Quinn R. ;
Sanders, Prashanthan ;
Trulock, Kevin M. .
CIRCULATION, 2020, 141 (16) :E750-E772
[7]  
Cohen AJ, 2017, LANCET, V389, P1907, DOI [10.1016/s0140-6736(17)30505-6, 10.1016/S0140-6736(17)30505-6]
[8]   Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation [J].
Conen, David ;
Chae, Claudia U. ;
Glynn, Robert J. ;
Tedrow, Usha B. ;
Everett, Brendan M. ;
Buring, Julie E. ;
Albert, Christine M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (20) :2080-2087
[9]   Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis [J].
Ettehad, Dena ;
Emdin, Connor A. ;
Kiran, Amit ;
Anderson, Simon G. ;
Callender, Thomas ;
Emberson, Jonathan ;
Chalmers, John ;
Rodgers, Anthony ;
Rahimi, Kazem .
LANCET, 2016, 387 (10022) :957-967
[10]  
Ezzati M, 2017, LANCET, V390, P2627, DOI [10.1016/S0140-6736(17)32129-3, 10.1016/s0140-6736(17)32129-3]